
A recent study investigated the efficacy and safety of combining vaginal isosorbide mononitrate (ISMN) with misoprostol for first- and second-trimester abortions. The meta-analysis, based on seven randomized clinical trials, showed a significant reduction in induction abortion interval by 4.21 hours (95% CI: -7.45 to -0.97, P = 0.01) when ISMN was added to misoprostol for second-trimester abortions. Additionally, the combination increased the odds of a completed abortion by 3.76 times (95% CI: 1.08 to 13.15, P = 0.04) compared to misoprostol alone. These findings suggest that incorporating ISMN with misoprostol may enhance the effectiveness of non-surgical medication abortion methods, potentially reducing the need for surgical interventions.
Like
Save
Share